Raquel Guttman

Mrs. Raquel Guttman


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
CACynthia Avendaño-Portugal
Cynthia Avendaño-Portugal
MMMariela Montaño-Samaniego
Mariela Montaño-Samaniego
RGRaquel Guttman
Raquel Guttman
DEDiana Marcela Bravo Estupiñan
Diana Marcela Bravo Estupiñan
MIMiguel Ángel Antonio Ibáñez-Hernández
Miguel Ángel Antonio Ibáñez-Hernández
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial roles in regulating gene expression, and their dysregulation is implicated in various human diseases. Over the years, several research groups have identified miRNAs as promising therapeutic targets for intervention. Therapeutic strategies involve either overexpression or knockdown of specific miRNAs. This review aims to provide a comprehensive overview of synthetic poly-miRNAs and miRNA sponges, highlighting their therapeutic applications. It begins with an introduction to miRNAs and their role in human diseases, followed by a detailed discussion on synthetic poly-miRNAs and miRNA sponges by exploring their application in cardiovascular, inflammatory, autoimmune, and metabolic disorders, as well as in cancer therapy. Additionally, strategies for targeted delivery, challenges, and limitations of these therapies are addressed.

4 April 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
MIMiguel Ángel Antonio Ibáñez-Hernández
Miguel Ángel Antonio Ibáñez-Hernández
CACynthia Avendaño-Portugal
Cynthia Avendaño-Portugal
MMMariela Montaño-Samaniego
Mariela Montaño-Samaniego
RGRaquel Guttman
Raquel Guttman
DEDiana Marcela Bravo Estupiñan
Diana Marcela Bravo Estupiñan
MicroRNAs (miRNAs) are small, non-coding RNA molecules that play crucial roles in regulating gene expression, and their dysregulation is implicated in various human diseases. Over the years, several research groups have identified miRNAs as promising therapeutic targets for intervention. Therapeutic strategies involve either the overexpression or knockdown of specific miRNAs. This review aims to provide a comprehensive overview of synthetic poly-miRNAs and miRNA sponges, highlighting their therapeutic applications. It begins with an introduction to miRNAs and their role in human diseases, followed by a detailed discussion on synthetic poly-miRNAs and miRNA sponges by exploring their application in cardiovascular, inflammatory, autoimmune, and metabolic disorders, as well as in cancer therapy. Additionally, strategies for targeted delivery, challenges, and limitations of these therapies are addressed.